3-Aminopyrazole structure
|
Common Name | 3-Aminopyrazole | ||
---|---|---|---|---|
CAS Number | 1820-80-0 | Molecular Weight | 83.092 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 334.5±15.0 °C at 760 mmHg | |
Molecular Formula | C3H5N3 | Melting Point | 34-37 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 182.6±7.6 °C | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Name | 3-Aminopyrazole |
---|---|
Synonym | More Synonyms |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 334.5±15.0 °C at 760 mmHg |
Melting Point | 34-37 °C(lit.) |
Molecular Formula | C3H5N3 |
Molecular Weight | 83.092 |
Flash Point | 182.6±7.6 °C |
Exact Mass | 83.048347 |
PSA | 54.70000 |
LogP | -0.29 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.648 |
Storage condition | 2-8°C |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive; Xi:Irritant |
Risk Phrases | R22;R34;R36/37/38 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 3263 8/PG 2 |
WGK Germany | 3 |
Hazard Class | 8.0 |
HS Code | 2933199090 |
~99% 3-Aminopyrazole CAS#:1820-80-0 |
Literature: Quinn, John F.; Bryant, Cole E.; Golden, Kathryn C.; Gregg, Brian T. Tetrahedron Letters, 2010 , vol. 51, # 5 p. 786 - 789 |
~60% 3-Aminopyrazole CAS#:1820-80-0 |
Literature: Ege, Guenter; Franz, Hermann Journal of Heterocyclic Chemistry, 1982 , vol. 19, p. 1267 - 1273 |
~% 3-Aminopyrazole CAS#:1820-80-0 |
Literature: Helvetica Chimica Acta, , vol. 39, p. 986,988 |
Precursor 3 | |
---|---|
DownStream 10 | |
HS Code | 2933199090 |
---|---|
Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Trypanotoxic activity of thiosemicarbazone iron chelators.
Exp. Parasitol. 150 , 7-12, (2015) Only a few drugs are available for treating sleeping sickness and nagana disease; parasitic infections caused by protozoans of the genus Trypanosoma in sub-Saharan Africa. There is an urgent need for ... |
|
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
Cancer Res. 75 , 2863-74, (2015) Generalized strategies to improve breast cancer treatment remain of interest to develop. In this study, we offer preclinical evidence of an important metabolic mechanism underlying the antitumor activ... |
|
Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.
Behav. Brain Res. 291 , 342-50, (2015) Studies have demonstrated that administration of the neuronal nicotinic receptor agonist varenicline to rats with olivocerebellar lesions attenuates balance deficits on a rotorod and balance beam, but... |
3-Pyrazolamine |
5-Pyrazolamine |
1H-pyrazol-3-ylamine |
EINECS 217-338-1 |
5-AMINOPYRAZOLE |
3-amino-pyrazole |
3-AMINOPYROZOLE |
1H-Pyrazol-5-amine |
3-Amino-pyrazol |
3-Aminopyarazole |
1H-pyrazol-3-amine |
MFCD00005236 |
3-AP |